Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

RAPP

Rapport Therapeutics (RAPP)

Rapport Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RAPP
DateTimeSourceHeadlineSymbolCompany
05/02/202509:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
05/02/202509:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
10/01/202522:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPPRapport Therapeutics Inc
10/01/202501:12GlobeNewswire Inc.CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersNASDAQ:RAPPRapport Therapeutics Inc
09/01/202523:00GlobeNewswire Inc.Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersNASDAQ:RAPPRapport Therapeutics Inc
07/12/202404:01GlobeNewswire Inc.Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical SeizuresNASDAQ:RAPPRapport Therapeutics Inc
14/11/202423:00GlobeNewswire Inc.Rapport Therapeutics to Present Data at American Epilepsy Society Annual MeetingNASDAQ:RAPPRapport Therapeutics Inc
08/11/202411:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
08/11/202410:27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
07/11/202423:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RAPPRapport Therapeutics Inc
07/11/202423:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPPRapport Therapeutics Inc
07/11/202423:00GlobeNewswire Inc.Rapport Therapeutics Reports Third Quarter Financials and Provides Business UpdateNASDAQ:RAPPRapport Therapeutics Inc
04/11/202423:00GlobeNewswire Inc.Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in NovemberNASDAQ:RAPPRapport Therapeutics Inc
05/09/202421:00GlobeNewswire Inc.Rapport Therapeutics to Present at Upcoming Epilepsy Medical ConferencesNASDAQ:RAPPRapport Therapeutics Inc
29/08/202421:00GlobeNewswire Inc.Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry SummitNASDAQ:RAPPRapport Therapeutics Inc
08/08/202421:00GlobeNewswire Inc.Rapport Therapeutics Reports Second Quarter Financials and Provides Business UpdateNASDAQ:RAPPRapport Therapeutics Inc
29/07/202421:00GlobeNewswire Inc.Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on PainNASDAQ:RAPPRapport Therapeutics Inc
13/06/202406:01GlobeNewswire Inc.Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private PlacementNASDAQ:RAPPRapport Therapeutics Inc
11/06/202409:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
11/06/202409:42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RAPPRapport Therapeutics Inc
11/06/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RAPPRapport Therapeutics Inc
07/06/202408:54GlobeNewswire Inc.Rapport Therapeutics Announces Pricing of Initial Public OfferingNASDAQ:RAPPRapport Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RAPP